Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

Costantino Errani

Status: Enrolling

Conditions: Bone Metastases

Treatments: Other: Analysis

Study type: Observational

Funder types: Other

Identifiers

NCT06524843

FRAIL-RAW

Details and patient eligibility

About

From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022.

A review will be made from the medical records, radiological imaging, and histological data of these patients

Enrollment: 250 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years
• Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases
• Availability of imaging and clinical data
• Availability of at least one follow-up during the last 12 months form diagnosis

Exclusion criteria

• At least one inclusion creteria not met

Trial design

250 participants in 1 patient group

Patients

Description:

Male and female patients affected by bone metastases derived from carcinoma, treated at Rizzoli Orthopaedic Institute from 01/01/2010 to 31/12/2022

Treatment:

Other: Analysis